Cat. No. | Product Name / Activity |
---|---|
5807 | M 084 hydrochloride |
TRPC4/5 channel blocker; antidepressant and anxiolytic | |
3629 | M 1145 |
Potent and selective GAL2 agonist | |
4917 | M 25 |
Potent Smoothened (Smo) receptor antagonist | |
6067 | M 30 dihydrochloride |
Potent and non-selective MAO inhibitor; also an iron chelator and antioxidant | |
2771 | M 344 |
Histone deacetylase inhibitor | |
1941 | m-3M3FBS |
Phospholipase C activator | |
1942 | o-3M3FBS |
Inactive analog of m-3M3FBS (Cat. No. 1941) | |
3425 | M40 |
Potent, non-selective galanin receptor antagonist | |
2697 | M617 |
Selective GAL1 agonist | |
5705 | M62812 |
TLR-4 inhibitor | |
5324 | M8 B hydrochloride |
Potent and selective TRPM8 channel blocker | |
2698 | M871 |
Selective GAL2 antagonist | |
4934 | MA 2029 |
Potent and selective, competitive motilin receptor antagonist; orally active | |
6382 | MAIT 203 |
APC-Asef (RhoGEF4) interaction inhibitor | |
0711 | MAP4 |
Potent group II mGlu agonist; also group III mGlu antagonist | |
6799 | MB 0223 |
Dynamin-related GTPase DRP1 partial inhibitor | |
6618 | MB 05032 |
Potent FBPase inhibitor; promotes HSC expansion | |
1900 | [Ala107]-MBP (104-118) |
Protein kinase C inhibitor | |
1901 | [Ala113]-MBP (104-118) |
Protein kinase C inhibitor | |
4077 | MC 1568 |
Selective HDAC class IIa inhibitor | |
5727 | MC 1742 |
Potent class I and IIb HDAC inhibitor | |
3806 | MCH (human, mouse, rat) |
Potent endogenous MCH agonist | |
3434 | [Ala17]-MCH |
Potent MCH receptor agonist | |
3438 | MCL 0020 |
Selective MC4 receptor antagonist | |
3763 | MCOPPB trihydrochloride |
Potent NOP receptor agonist | |
0336 | (RS)-MCPG |
Non-selective mGlu antagonist | |
3696 | (RS)-MCPG disodium salt |
Non-selective mGlu antagonist; disodium salt of (RS)-MCPG (Cat. No. 0336) | |
0337 | (S)-MCPG |
Non-selective mGlu antagonist; active isomer of (RS)-MCPG (Cat. No. 0336) | |
4205 | MDA 19 |
CB2 agonist | |
4173 | MDL 100907 |
Potent and selective 5-HT2A antagonist | |
0870 | MDL 11,939 |
5-HT2A antagonist | |
1436 | MDL 12330A hydrochloride |
Adenylyl cyclase inhibitor; also cyclic nucleotide PDE inhibitor | |
1194 | MDL 29,913 |
Selective NK2 antagonist | |
0640 | MDL 72222 |
5-HT3 antagonist | |
3709 | MDL 72527 |
Polyamine oxidase (PAO) inhibitor | |
0412 | MDL 72832 hydrochloride |
Potent 5-HT1A ligand | |
0411 | MDL 73005EF hydrochloride |
Potent and selective 5-HT1A partial agonist | |
3027 | (±)-MDMA hydrochloride |
Inhibitor of 5-HT and dopamine uptake; hallucinogenic | |
5054 | ME 0328 |
Selective PARP-3 inhibitor | |
4615 | MEDICA 16 |
FFA1 (GPR40) agonist; also inhibits ATP citrate lyase | |
1632 | MEN 10376 |
Potent, selective NK2 antagonist | |
3978 | MEN 11270 |
Selective B2 antagonist; analog of HOE 140 (Cat. No. 3014) | |
5875 | MES sodium salt |
Buffering agent | |
5887 | MES, free acid |
Commonly used buffer | |
4438 | MFZ 10-7 |
Negative allosteric modulator of mGlu5 receptors | |
3358 | MG 101 |
Calpain inhibitor; activates p53-dependent apoptosis | |
1748 | MG 132 |
Proteasome and calpain inhibitor. Inhibits NF-κB activation | |
6033 | (R)-MG 132 |
Potent 20S proteasome inhibitor | |
1356 | MG 624 |
α7 neuronal nAChR antagonist | |
5604 | MI 14 |
Potent and selective PI 4-kinase IIIβ inhibitor | |
5647 | MI 192 |
Potent and selective HDAC2/3 inhibitor | |
4707 | MI 2 dihydrochloride |
Menin-MLL interaction inhibitor | |
4848 | MI 2 (MALT1 inhibitor) |
MALT1 inhibitor | |
4762 | MIM1 |
Mcl-1 inhibitor; proapoptotic | |
3362 | MIRA-1 |
Restores mutant p53 activity; proapoptotic | |
4063 | MJ 15 |
Potent and selective CB1 antagonist | |
4415 | MK 0343 |
GABAA partial agonist; displays subtype selectivity | |
5272 | MK 0677 |
High affinity ghrelin receptor agonist | |
4622 | MK 1903 |
Potent and selective GPR109A (HCA2) agonist | |
0941 | MK 212 hydrochloride |
5-HT2C agonist | |
5842 | MK 386 |
Potent, selective human type 1 5α-reductase inhibitor | |
2338 | MK 571 |
Potent CysLT1 (LTD4) inverse agonist. Also MRP1 inhibitor | |
0924 | (+)-MK 801 maleate |
Non-competitive NMDA antagonist; acts at ion channel site | |
0955 | (-)-MK 801 maleate |
NMDA antagonist; less active enantiomer of (+)-MK 801 | |
1311 | MK 886 |
Inhibitor of 5-lipoxygenase-activating protein (FLAP) | |
5547 | MK6-83 |
TRPML channel activator | |
4621 | MKT 077 |
Binds mot-2; selectively cytotoxic in cancer cells | |
4854 | ML 00253764 hydrochloride |
Melanocortin MC4 receptor antagonist; brain penetrant | |
3499 | ML 10302 hydrochloride |
Potent and selective 5-HT4 partial agonist | |
4899 | ML 120B dihydrochloride |
Novel IKK2-selective inhibitor | |
4354 | ML 130 |
Inhibits NOD1-induced NF-κB activation | |
4549 | ML 133 hydrochloride |
Kir2 channel blocker | |
4266 | ML 141 |
Selective Cdc42 Rho family inhibitor | |
4172 | ML 145 |
GPR35 antagonist | |
5161 | ML 154 |
Potent Neuropeptide S receptor antagonist | |
4570 | ML 161 |
Inhibits PAR1-mediated platelet activation | |
4653 | ML 171 |
Selective NADPH oxidase 1 (NOX1) inhibitor | |
4957 | ML 179 |
Selective liver receptor homolog 1 (LRH1) inverse agonist | |
5599 | ML 18 |
BRS-3 antagonist; also GRPR agonist | |
6668 | ML 184 |
Selective GPR55 agonist; also promotes NSC proliferation and differentiation | |
4866 | ML 190 |
Selective κ opioid receptor antagonist | |
4860 | ML 193 |
Potent, selective GPR55 antagonist | |
4732 | ML 204 |
Selective TRPC4 blocker | |
5987 | (±)-ML 209 |
RORγt inverse agonist; suppresses Th17 cell differentiation | |
6429 | ML 210 |
Selectively kills mutant HRAS-expressing cells; glutathione peroxidase inhibitor; induces ferroptosis | |
4519 | ML 213 |
KV7.2 and KV7.4 channel opener | |
4507 | ML 218 hydrochloride |
CaV3.x blocker | |
4748 | ML 221 |
Apelin antagonist | |
4565 | ML 228 |
HIF pathway activator | |
5966 | ML 233 |
Non-peptide apelin agonist | |
4829 | ML 239 |
Breast cancer stem cell inhibitor | |
5153 | ML 240 |
ATP-competitive inhibitor of p97 ATPase | |
4777 | ML 277 |
Selective KV7.1 (KCNQ1) potassium channel activator; augments IKs current | |
4880 | ML 281 |
STK33 inhibitor | |
4976 | ML 289 |
Selective negative allosteric modulator of mGlu3 receptors | |
5380 | ML 297 |
Selective Kir3.1/3.2 (GIRK1/2) channel activator | |
4895 | ML 298 hydrochloride |
Selective PLD2 inhibitor | |
5733 | ML 311 |
Inhibits Mcl-1-BIM interaction | |
5700 | ML 315 hydrochloride |
Inhibitor of Clk and DYRK kinases | |
6435 | ML 323 |
Potent and selective USP1-UAF1 allosteric inhibitor | |
5625 | ML 334 |
Inhibitor of Keap1- Nrf2 interaction | |
6887 | ML 335 |
Selective K2P2.1 (TREK-1) and K2P10.1 (TREK-2) activator | |
4982 | ML 337 |
Selective negative allosteric modulator of mGlu3 receptors | |
5943 | ML 339 |
Potent and selective hCXCR6 antagonist | |
4586 | ML 3403 |
p38 inhibitor | |
4945 | ML 347 |
Potent and selective ALK1 and ALK2 inhibitor | |
5345 | ML 348 |
Selective and reversible lysophospholipase 1 (LYPLA1) inhibitor | |
5344 | ML 349 |
Selective and reversible lysophospholipase 2 (LYPLA2) inhibitor | |
6448 | ML 351 |
Selective 12/15 LOX inhibitor; active in vivo | |
5387 | ML 354 |
Selective PAR4 antagonist | |
5337 | ML 365 |
Potent and selective K2P3.1 (TASK-1) channel blocker | |
5738 | ML 382 |
MRGPRX1 positive allosteric modulator | |
6243 | ML 385 |
Nrf2 inhibitor; phenotypically lethal | |
6888 | ML 402 |
Selective TREK channel activator | |
6889 | ML 418 |
Kir 7.1 inhibitor; also inhibits Kir 6.2 | |
6886 | ML 67-33 |
K2P2.1 (TREK-1), K2P10.1 (TREK-2) and K2P4.1 (TRAAK) channel activator | |
4310 | ML 7 hydrochloride |
Selective inhibitor of myosin light chain kinase | |
0431 | ML 9 hydrochloride |
Myosin light chain kinase inhibitor | |
4746 | ML SA1 |
Activator of TRPML channels | |
1885 | MLCK inhibitor peptide 18 |
Selective inhibitor of myosin light chain kinase | |
4582 | MLR 1023 |
Selective allosteric activator of Lyn kinase | |
6171 | MLS 1547 |
G protein-biased D2 partial agonist | |
5756 | MLi-2 |
Potent and selective LRRK2 inhibitor | |
7053 | MM 07 |
Apelin receptor biased agonist; exhibits bias for the G protein pathway | |
5307 | MM 102 |
Potent WDR5/MLL interaction inhibitor | |
3822 | MM 11253 |
RARγ-selective antagonist | |
5992 | MM 54 |
Potent apelin antagonist | |
0933 | MM 77 dihydrochloride |
5-HT1A (postsynaptic) antagonist | |
5683 | MMAE |
Potent dolastatin 10 analog; antitumor | |
4511 | MMF |
Activator of Nrf2 pathway; primary metabolite of DMF (Cat. No. 4512) | |
6858 | MMG 11 |
TLR2 antagonist | |
3537 | MMK 1 |
Potent and selective FPR2 agonist | |
2963 | MMPIP hydrochloride |
Potent and selective negative allosteric modulator of mGlu7 receptors | |
0552 | MMPX |
PDE1 inhibitor | |
4388 | MNI 137 |
Selective negative allosteric modulator of group II mGlu receptors | |
2224 | MNI-caged-NMDA |
Caged NMDA | |
1490 | MNI-caged-L-glutamate |
Stable photoreleaser of L-glutamate | |
2277 | MNI-caged-D-aspartate |
Caged D-aspartate; NMDA agonist | |
2492 | MNITMT |
Novel, non-toxic immunosuppressive agent | |
2877 | MNS |
Selective inhibitor of Src and Syk | |
2568 | MOG (35-55) |
Encephalitogenic myelin oligodendrocyte glycoprotein fragment | |
5770 | MONNA |
Potent TMEM16A (Anoctamin-1) blocker | |
5508 | MOPS |
Widely used buffering agent | |
5877 | MOPS, sodium salt |
Used as a buffering agent. MOPS supplied as powder. | |
5888 | MOPSO, free acid |
Buffer for biochemistry and molecular biology | |
5803 | MP A08 |
Selective ATP competitive SphK1 and 2 inhibitor; cell permeable | |
5231 | MPC 6827 hydrochloride |
Inhibitor of microtubule polymerization; antimitotic and antitumor | |
0973 | MPDC |
Potent inhibitor of L-glutamate uptake. Less activity as a substrate compared to its parent compound, L-trans-2,4-PDC (Cat. No. 0298) | |
1035 | 8-M-PDOT |
Melatonin agonist | |
1212 | MPEP hydrochloride |
Potent mGlu5 antagonist; also positive allosteric modulator of mGlu4 receptors | |
0661 | 2-MPMDQ |
Potent, selective α1 antagonist. Also σ2 ligand | |
1991 | MPP dihydrochloride |
Highly selective ERα antagonist | |
5033 | 2-MPPA |
Selective glutamate carboxypeptidase II (GCP II) inhibitor; orally bioavailable | |
0853 | MPPG |
Group III and group II mGlu antagonist; more selective for group III than group II | |
0783 | N-MPPP Hydrochloride |
Selective κ agonist | |
7228 | MPro 13b New |
Coronavirus Mpro inhibitor | |
7230 | MPro N3 |
Coronavirus Mpro inhibitor | |
4041 | MRE 3008F20 |
Highly potent and selective adenosine A3 receptor antagonist | |
3817 | MRK 016 |
α5-selective GABAA inverse agonist | |
4000 | MRK 560 |
γ-secretase inhibitor; attenuates amyloid plaque deposition | |
6803 | MRK 740 |
Potent PRDM9 inhibitor | |
1217 | MRS 1220 |
Highly potent and selective hA3 antagonist | |
1385 | MRS 1334 |
Potent, highly selective hA3 antagonist | |
1584 | MRS 1706 |
Potent and selective A2B inverse agonist | |
2752 | MRS 1754 |
Selective A2B antagonist | |
0900 | MRS 2179 tetrasodium salt |
Selective P2Y1 antagonist | |
2402 | MRS 2211 |
Competitive P2Y13 antagonist | |
2158 | MRS 2279 |
Selective, high affinity P2Y1 antagonist | |
2157 | MRS 2365 |
Highly potent and selective P2Y1 agonist | |
2159 | MRS 2500 tetraammonium salt |
Highly potent and selective P2Y1 antagonist | |
2146 | MRS 2578 |
Selective P2Y6 antagonist | |
2915 | MRS 2690 |
Potent P2Y14 agonist | |
2502 | MRS 2693 trisodium salt |
Selective P2Y6 agonist | |
3884 | MRS 2768 tetrasodium salt |
Selective P2Y2 agonist | |
5633 | MRS 2905 |
Potent and selective P2Y14 receptor agonist | |
4260 | MRS 2957 triethylammonium salt |
Potent and selective P2Y6 agonist | |
4261 | MRS 4062 triethylammonium salt |
Selective P2Y4 receptor agonist | |
5428 | MRS 5698 |
High affinity and selective A3 agonist | |
4585 | MRT 10 |
Smoothened (Smo) antagonist | |
5134 | MRT 67307 dihydrochloride |
Salt inducible kinase (SIK) inhibitor | |
5067 | MRT 68601 hydrochloride |
Potent TBK inhibitor | |
5780 | MRT 68921 dihydrochloride |
Potent ULK inhibitor; inhibits autophagy | |
5713 | MS 023 dihydrochloride |
Potent and selective type I PRMT inhibitor | |
6299 | MS 15203 |
Potent and selective GPR171 partial agonist | |
6298 | MS 21570 |
GPR171 antagonist | |
4208 | MS 245 oxalate |
High affinity 5-HT6 antagonist | |
6208 | MS 275 |
HDAC (Class I) inhibitor | |
5173 | MS 436 |
Potent and selective BRD4(1) inhibitor | |
7353 | MSA 2 New |
Non-nucleotide STING agonist; orally bioavailable | |
5641 | MSC 2032964A |
Potent and selective ASK1 inhibitor; orally bioavailable | |
5954 | MSG 606 |
Potent human MC1 receptor antagonist; also MC3 and MC5 partial agonist | |
3424 | γ1-MSH |
Selective MC3 receptor agonist | |
4272 | [D-Trp8]-γ-MSH |
Selective MC3 receptor agonist | |
3013 | [Nle4,D-Phe7]-α-MSH |
Melanocortin receptor agonist | |
2584 | α-MSH |
Endogenous melanocortin receptor agonist | |
0803 | MSOP |
Specific group III mGlu antagonist | |
0854 | MSPG |
Group III and group II mGlu antagonist | |
2921 | MTEP hydrochloride |
Potent and selective mGlu5 antagonist | |
0855 | MTPG |
Group II/group III mGlu antagonist; more selective for group II than group III | |
5224 | MTT |
Reagent used in the measurement of cell proliferation | |
6154 | MZ 1 |
(+)-JQ1 based PROTAC that selectively degrades BRD4 in cells | |
3061 | Macbecin I |
Hsp90 inhibitor | |
0479 | Malonoben |
Oxidative phosphorylation uncoupler | |
5938 | Mambalgin 1 |
Selective ASIC1a inhibitor; analgesic | |
6856 | α-Mangostin |
Inhibits proliferation and induces apoptosis selectively in pancreatic CSCs and cancer cell lines | |
0935 | Maprotiline hydrochloride |
Noradrenalin re-uptake inhibitor | |
3756 | Maraviroc |
Selective CCR5 antagonist | |
3563 | Margatoxin |
Potent KV1.3 channel blocker | |
2631 | Marimastat |
Broad spectrum MMP inhibitor | |
1192 | Mastoparan |
Activates Gi and Go | |
4949 | MaxiPost |
Potassium channel modulator; exerts subtype-specific effects | |
2148 | (±)-McN 5652 |
Potent, orally active 5-HT uptake inhibitor; also inhibits noradrenalin and dopamine uptake in vitro | |
1384 | McN-A 343 |
Selective M1 muscarinic agonist | |
3982 | Mdivi 1 |
Selective dynamin inhibitor; attenuates mitochondrial division and apoptosis | |
3873 | MeBIO |
Inactive analog of BIO (Cat. No. 3194) | |
2281 | 2'-MeCCPA |
Very selective and potent A1 receptor agonist | |
2843 | Mecamylamine hydrochloride |
Non-competitive nAChR antagonist | |
4245 | Meclizine dihydrochloride |
Human pregnane X receptor agonist; H1 antagonist | |
5160 | Medetomidine hydrochloride |
Potent and highly selective α2 agonist | |
6819 | Mefloquine hydrochloride |
Cx36 and Cx50 gap channel blocker; also antimalarial and antischistosomal | |
6285 | Megestrol Acetate |
Synthetic progesterone analog | |
1929 | Melanocyte-stimulating hormone release inhibiting factor |
Inhibitor of α-MSH release; inhibits opioid effects in vivo | |
2566 | Melanotan II |
High affinity melanocortin receptor agonist | |
3550 | Melatonin |
Endogenous hormone; agonist at MT1 and MT2 | |
1193 | Melittin |
Inhibits Gs and stimulates Gi activity | |
2495 | Melperone hydrochloride |
5-HT2A antagonist; also D2 antagonist; neuroleptic | |
4619 | Melphalan |
DNA alkylating agent; cytotoxic and antineoplastic | |
0773 | Memantine hydrochloride |
NMDA antagonist; acts at ion channel site | |
3276 | Mephenytoin |
CYP2C19 substrate. Anticonvulsant | |
3636 | Meptazinol hydrochloride |
μ1 partial agonist | |
0660 | Mepyramine maleate |
Selective H1 inverse agonist | |
4103 | 6-Mercaptopurine |
Purine analog; inhibits DNA and RNA synthesis | |
3053 | Mesopram |
Orally active PDE4 inhibitor | |
1644 | Mesulergine hydrochloride |
5-HT2A and 5-HT2C antagonist; also D2-like partial agonist | |
1443 | Metastin (human) |
Potent, endogenous ligand for kisspeptin receptor | |
0590 | Metergoline |
5-HT2 antagonist. Also 5-HT1 antagonist and 5-HT1D ligand. Has moderate affinity for 5-HT6 and high affinity for 5-HT7 | |
2864 | Metformin hydrochloride |
Activator of LKB1/AMPK; antidiabetic agent | |
1230 | Methotrexate |
Cytotoxic agent | |
4920 | Methoxy-X04 |
Fluorescent amyloid β detector; brain penetrant | |
1807 | 2-Methoxyestradiol |
Apoptotic and antiangiogenic agent | |
4814 | Methoxyresorufin |
Fluorometric CYP450 substrate | |
0577 | Methyl 2,5-dihydroxycinnamate |
EGFR-kinase inhibitor | |
0386 | 3-Methyl-GABA |
Activator of GABA amino-transferase | |
3513 | N2-Methyl-L-arginine |
Lysosomal system c L-arginine uptake inhibitor | |
5698 | 1-Methyl-D-tryptophan |
Indoleamine 2,3-dioxygenase (IDO) inhibitor | |
3977 | 3-Methyladenine |
Class III PI 3-kinase inhibitor; also inhibits autophagy | |
0584 | L-(-)-α-Methyldopa |
Aromatic L-amino acid decarboxylase inhibitor | |
3213 | Methylene Blue |
Biological stain | |
3209 | α,β-Methyleneadenosine 5'-triphosphate trisodium salt |
Non-selective P2 agonist | |
0549 | Methylergometrine maleate |
Active metabolite of methysergide (Cat. No. 1064) | |
0588 | 5-Methylfurmethiodide |
Potent muscarinic agonist | |
0811 | (±)-threo-3-Methylglutamic acid |
EAAT2 and EAAT4 blocker | |
0569 | (R)-(-)-α-Methylhistamine dihydrobromide |
Potent, standard H3 agonist | |
2342 | 4-Methylhistamine dihydrochloride |
Selective, high affinity H4 agonist | |
0573 | Nα-Methylhistamine dihydrochloride |
Non-selective H3 agonist | |
0776 | (S)-Methylisothiourea sulfate |
Highly selective iNOS inhibitor | |
1042 | N-Methyllidocaine iodide |
Enhances biosynthesis of phosphatidylinositol | |
1029 | Methyllycaconitine citrate |
Selective α7 neuronal nAChR antagonist | |
4979 | Methylmalonate |
Succinate dehydrogenase inhibitor | |
6109 | Methylnaltrexone bromide |
μ antagonist; peripherally restricted | |
1812 | Threo-methylphenidate hydrochloride |
Inhibitor of dopamine and noradrenalin transporters. Psychomotor stimulant | |
4819 | Methylprednisolone |
Glucocorticoid receptor agonist | |
3017 | 1-Methylpsilocin |
Potent and selective 5-HT2C agonist | |
0566 | N-Methylquipazine dimaleate |
5-HT3 agonist | |
1624 | 2-Methylthioadenosine diphosphate trisodium salt |
Potent agonist at P2Y1, P2Y12 and P2Y13 | |
1062 | 2-Methylthioadenosine triphosphate tetrasodium salt |
Non-selective P2 agonist | |
1064 | Methysergide maleate |
5-HT1/5-HT2 antagonist | |
3256 | Metoprolol tartrate |
Selective β1 antagonist | |
3292 | Metyrapone |
11-β hydroxylase inhibitor | |
1526 | Mevastatin |
HMG-CoA reductase inhibitor | |
2596 | Mexiletine hydrochloride |
Na+ channel blocker; antiarrhythmic agent | |
0997 | Mianserin hydrochloride |
5-HT2 antagonist. Has moderate affinity for 5-HT6 | |
2198 | Mibefradil dihydrochloride |
CaV3.x blocker | |
3016 | Miconazole nitrate |
Azole antifungal agent | |
2832 | Midazolam hydrochloride |
Benzodiazepine agonist | |
1479 | Mifepristone |
Progesterone and glucocorticoid receptor antagonist | |
4985 | Miglitol |
α-glucosidase inhibitor | |
3117 | Miglustat hydrochloride |
α-glucosidase I and II inhibitor; also inhibits ceramide-specific glycosyltransferases and exhibits broad spectrum antiviral activity | |
2604 | Milameline hydrochloride |
Muscarinic receptor agonist | |
3286 | Milnacipran hydrochloride |
5-HT and NA reuptake inhibitor (SNRI) | |
1504 | Milrinone |
PDE3 inhibitor | |
3268 | Minocycline hydrochloride |
Antibiotic. Displays neuroprotective effects | |
0583 | Minoxidil |
Kir6 channel (KATP) opener | |
7070 | Mirabegron |
Potent and selective β3 agonist | |
3190 | Mirin |
MRN-ATM pathway inhibitor | |
7091 | Miro1 Reducer New |
Promotes mitochondrial Rho GTPase 1 (Miro1) degradation | |
2018 | Mirtazapine |
Potent 5-HT2 antagonist; also 5-HT3, H1 and α2 antagonist; antidepressant | |
2297 | Misoprostol |
Cytoprotective PGE1 analog | |
4224 | MitMAB |
Dynamin inhibitor | |
1489 | Mithramycin A |
Inhibitor of DNA and RNA polymerase | |
6444 | MitoMark Green I |
Green fluorescent mitochondrial stain; cell permeable | |
6445 | MitoMark Red I |
Red fluorescent mitochondrial stain; cell permeable | |
4428 | MitoPY1 |
Fluorescent mitochondrial hydrogen peroxide indicator | |
6898 | Mitochondrial fusion promoter M1 |
Mitochondrial fusion promoter | |
5799 | Mitoglitazone |
Insulin sensitizer; exhibits low binding affinity at PPARγ | |
3258 | Mitomycin C |
DNA cross-linking antitumor agent | |
4250 | Mitoxantrone dihydrochloride |
Topoisomerase II inhibitor; immunosuppressive and antineoplastic agent | |
4395 | Moclobemide |
Reversible MAO-A inhibitor | |
1811 | Modafinil |
Psychostimulant | |
6131 | (R)-Modafinil |
Dopamine uptake inhibitor | |
4115 | Mometasone furoate |
Synthetic corticosteroid; anti-inflammatory agent | |
1305 | Monastrol |
Selective inhibitor of mitotic kinesin Eg5 | |
5223 | Monensin sodium salt |
Sodium ionophore; antibacterial agent | |
5904 | Montelukast sodium |
CysLT1 and GPR17 antagonist | |
5158 | Morphine hydrochloride |
Narcotic opioid analgesic | |
2844 | Mosapride citrate |
5-HT4 agonist and 5-HT3 antagonist | |
2264 | Motilin (human, porcine) |
Endogenous peptide regulator of gastrointestinal motility | |
5142 | Mps1-IN-1 dihydrochloride |
Selective Mps1 kinase inhibitor | |
6366 | Muramyl Dipeptide |
Activates NOD2 receptors | |
3816 | Muristerone A |
Stimulates Bcl-XL mRNA transcription; antiapoptotic | |
3074 | (+)-Muscarine iodide |
Muscarinic receptor agonist | |
0289 | Muscimol |
Potent GABAA agonist; also GABAA-ρ partial agonist | |
4102 | Mycophenolate mofetil |
Inosine monophosphate dehydrogenase (IMPDH) inhibitor | |
1505 | Mycophenolic acid |
Inosine monophosphatase dehydrogenase (IMPDH) inhibitor | |
3399 | Myelin Basic Protein (87-99) |
Major antigenic component implicated in the pathophysiology of multiple sclerosis | |
6189 | Myricetin |
Irreversible TrxR inhibitor | |
0567 | (±)-Myristoylcarnitine chloride |
Intermediate in lipid metabolism |